1-10 of 10
Philip A Haddad, MD
Close
Sort by
Journal Articles

Comparative Efficacy of First-Line Chemotherapy-Free Combinations in Chronic Lymphocytic Leukemia (CLL): A Network Meta-Analysis

Philip A Haddad, MD, Nowell Ganey, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-136411
Published: 2020
Journal Articles

The Impact of Rituximab on the Clinical Outcomes of Primary Central Nervous System Lymphoma (PCNSL) When Added to Combination Chemotherapy: A Comprehensive Meta-Analysis

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136427
Published: 2020
Journal Articles

Establishing the Velocity of M-Protein Decline (V MD ) Value in Response to Multiple Myeloma Therapy That Best Predicts M-Protein of Zero

Philip A Haddad, MD, Nowell Ganey, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41.
https://doi.org/10.1182/blood-2020-136423
Published: 2020
Journal Articles

Clinicopathologic Determinants of Survival in Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma (MEITL): Analysis of a Pooled Database

Philip A Haddad, MD, Neelakanta Dadi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-136471
Published: 2020
Journal Articles

The Impact of Chromothripsis on the Clinical Outcomes of Acute Myeloid Leukemia (AML): A Meta-Analysis

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-136404
Published: 2020
Journal Articles

Comparative Efficacy of First-Line Regimens in Relapsed/Refractory Mantle Cell Lymphoma (MCL): A Proportional Meta-Analysis

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
https://doi.org/10.1182/blood-2020-136416
Published: 2020
Journal Articles

Epidemiology and Clinicopathology of Hepatosplenic T-Cell Lymphoma (HSTCL): Analysis of a Pooled Database

Philip A Haddad, MD, Dalia Hammoud, MD, Kevin M. Gallagher, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-136463
Published: 2020
Journal Articles

Activity of Rituximab-Bendamustine (RB) Combination in Nodular Lymphocyte Predominant Hodgkins Lymphoma (NLPHL)

Srinivas S Devarakonda, MD, Philip A Haddad, MD
Journal: Blood
Blood (2012) 120 (21): 4894.
https://doi.org/10.1182/blood.V120.21.4894.4894
Published: 2012
Journal Articles

Efficacy of Short Oral Leucovorin Rescue (SOLR) In Managing Recurrent Pralatrexate (Folotyn) Induced Mucositis (RPIM) Despite Dose Reduction

Philip A Haddad, MD
Journal: Blood
Blood (2011) 118 (21): 4745.
https://doi.org/10.1182/blood.V118.21.4745.4745
Published: 2011
Journal Articles

Bortezomib Alone or in Combinination with Doxil Is Active in Adult Refractory Multi-System Langerhans Cell Histiocytosis (LCH).

Philip A. Haddad, MD
Journal: Blood
Blood (2007) 110 (11): 3835.
https://doi.org/10.1182/blood.V110.11.3835.3835
Published: 2007